PublicaciĂłn: 4TH BOOSTER-DOSE SARS-COV-2 HETEROLOGOUS AND HOMOLOGOUS VACCINATION IN RHEUMATOLOGICAL PATIENTS
Fecha
2024
Autores
TĂtulo de la revista
ISSN de la revista
TĂtulo del volumen
Editor
Frontiers in Immunology
Resumen
TO EVALUATE THE IMMUNE RESPONSE TO THE SARS-COV-2 VACCINES IN ADULTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES (IMRDS) IN COMPARISON TO HEALTHY INDIVIDUALS, OBSERVED 1-20 WEEKS FOLLOWING THE FOURTH VACCINE DOSE. ADDITIONALLY, TO EVALUATE THE IMPACT OF IMMUNOSUPPRESSIVE THERAPIES, VACCINATION SCHEDULES, THE TIME INTERVAL BETWEEN VACCINATION AND SAMPLE COLLECTION ON THE VACCINE?S IMMUNE RESPONSE.
PERFORMING A COMPARISON BETWEEN THE VARIANTS, WUHAN VS OMICRON, WE NOTICED THAT THERE WERE SIGNIFICANT DIFFERENCES (P
DescripciĂłn
Palabras clave
SARS-CoV-2, immunosuppressive therapies, humoral IgG, COVID-19 vaccines, autoimmune rheumatic diseases
